Hamlet Abnousi
Amministratore Delegato presso Abnousi Corporate Finance
Profilo
Hamlet Abnousi is the founder of Scitech Global Ventures, Inc. founded in 2012.
He is currently the Chief Executive Officer at Abnousi Corporate Finance since 2007 and at Novobind Livestock Therapeutics, Inc. since 2012.
Mr. Abnousi's former position was as an Independent Director at Millennial Potash Corp.
He received his undergraduate degree from the University of British Columbia in 2000.
Posizioni attive di Hamlet Abnousi
| Società | Posizione | Inizio |
|---|---|---|
| Abnousi Corporate Finance | Amministratore Delegato | 01/12/2007 |
Novobind Livestock Therapeutics, Inc.
 Novobind Livestock Therapeutics, Inc. BiotechnologyHealth Technology Novobind Livestock Therapeutics, Inc. develops livestock therapeutics. Its molecules specifically target and neutralize multiple virulence factors necessary for the survival, infection, and proliferation of Salmonella in the GI. The company is headquartered in Vancouver, Canada. | Amministratore Delegato | 01/10/2012 |
Precedenti posizioni note di Hamlet Abnousi
| Società | Posizione | Fine |
|---|---|---|
| Scitech Global Ventures, Inc. | Fondatore | - |
| MILLENNIAL POTASH CORP. | Direttore/Membro del Consiglio | - |
Formazione di Hamlet Abnousi
| University of British Columbia | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| MILLENNIAL POTASH CORP. | Non-Energy Minerals |
| Aziende private | 3 |
|---|---|
| Abnousi Corporate Finance | |
| Scitech Global Ventures, Inc. | |
Novobind Livestock Therapeutics, Inc.
Novobind Livestock Therapeutics, Inc. BiotechnologyHealth Technology Novobind Livestock Therapeutics, Inc. develops livestock therapeutics. Its molecules specifically target and neutralize multiple virulence factors necessary for the survival, infection, and proliferation of Salmonella in the GI. The company is headquartered in Vancouver, Canada. | Health Technology |
- Borsa valori
- Insiders
- Hamlet Abnousi
